| Scrip Code | 532296 |
|---|---|
| NSE Symbol | GLENMARK |
| MSEI Symbol | NOTLISTED |
| ISIN | INE935A01035 |
| Name of company | Glenmark Pharmaceuticals Limited |
| Type of company | Main Board |
| Class of security | Equity |
| Date of start of financial year | 01-04-2025 |
| Date of end of financial year | 31-03-2026 |
| Date of board meeting when results were approved | 30-01-2026 |
| Date on which prior intimation of the meeting for considering financial results was informed to the exchange | 19-01-2026 |
| Description of presentation currency | INR |
| Level of rounding used in financial results | Lakhs |
| Reporting Type | Quarterly |
| Reporting Quarter | Third quarter |
| Nature of report standalone or consolidated | Standalone |
| Whether results are audited or unaudited for the quarter ended | Unaudited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended | Unaudited |
| Segment Reporting | Single segment |
| Description of single segment | PHARMACEUTICALS |
| Start date and time of board meeting | 30-01-2026 16:30:00 |
| End date and time of board meeting | 30-01-2026 18:40:00 |
| Whether cash flow statement is applicable on company | |
| Type of cash flow statement | |
| Declaration of unmodified opinion or statement on impact of audit qualification | Not applicable |
| Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? | No |
| No. of times funds raised during the quarter | |
| Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? | No |
| The Company is debt free | |
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-10-2025 | 01-04-2025 |
| B | Date of end of reporting period | 31-12-2025 | 31-12-2025 |
| C | Whether results are audited or unaudited | Unaudited | Unaudited |
| D | Nature of report standalone or consolidated | Standalone | Standalone |
| 1 | Income | ||
| Revenue from operations | 2,35,993.50 | 6,29,352.30 | |
| Other income | 10,905.60 | 46,414.70 | |
| Total income | 2,46,899.10 | 6,75,767.00 | |
| 2 | Expenses | ||
| (a) | Cost of materials consumed | 70,959.50 | 2,05,465.50 |
| (b) | Purchases of stock-in-trade | 10,465.60 | 29,529.40 |
| (c) | Changes in inventories of finished goods, work-in-progress and stock-in-trade | 5,677.40 | (10,448.60) |
| (d) | Employee benefit expense | 46,694.70 | 1,32,906.50 |
| (e) | Finance costs | 2,197.90 | 6,083.30 |
| (f) | Depreciation, depletion and amortisation expense | 5,918.30 | 17,575.60 |
| (f) | Other Expenses | ||
| 1 | Other Expenses | 52,625.70 | 1,67,312.80 |
| Total other expenses | 52,625.70 | 1,67,312.80 | |
| Total expenses | 1,94,539.10 | 5,48,424.50 | |
| 3 | Total profit before exceptional items and tax | 52,360.00 | 1,27,342.50 |
| 4 | Exceptional items | (17,707.30) | (1,43,209.90) |
| 5 | Total profit before tax | 34,652.70 | (15,867.40) |
| 6 | Tax expense | ||
| 7 | Current tax | 0.00 | 0.00 |
| 8 | Deferred tax | 6,446.10 | (3,177.70) |
| 9 | Total tax expenses | 6,446.10 | (3,177.70) |
| 10 | Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement | 0.00 | 0.00 |
| 11 | Net Profit Loss for the period from continuing operations | 28,206.60 | (12,689.70) |
| 12 | Profit (loss) from discontinued operations before tax | 0.00 | 0.00 |
| 13 | Tax expense of discontinued operations | 0.00 | 0.00 |
| 14 | Net profit (loss) from discontinued operation after tax | 0.00 | 0.00 |
| 15 | Share of profit (loss) of associates and joint ventures accounted for using equity method | 0.00 | 0.00 |
| 16 | Total profit (loss) for period | 28,206.60 | (12,689.70) |
| 17 | Other comprehensive income net of taxes | 194.40 | (1,321.00) |
| 18 | Total Comprehensive Income for the period | 28,401.00 | (14,010.70) |
| 19 | Total profit or loss, attributable to | ||
| Profit or loss, attributable to owners of parent | |||
| Total profit or loss, attributable to non-controlling interests | |||
| 20 | Total Comprehensive income for the period attributable to | ||
| Comprehensive income for the period attributable to owners of parent | |||
| Total comprehensive income for the period attributable to owners of parent non-controlling interests | |||
| 21 | Details of equity share capital | ||
| Paid-up equity share capital | 2,822.00 | 2,822.00 | |
| Face value of equity share capital | 1 | 1 | |
| 27 | Details of debt securities | ||
| 22 | Reserves excluding revaluation reserve | ||
| 23 | Earnings per share | ||
| i | Earnings per equity share for continuing operations | ||
| Basic earnings (loss) per share from continuing operations | 10 | -4.5 | |
| Diluted earnings (loss) per share from continuing operations | 9.99 | -4.5 | |
| ii | Earnings per equity share for discontinued operations | ||
| Basic earnings (loss) per share from discontinued operations | 0 | 0 | |
| Diluted earnings (loss) per share from discontinued operations | 0 | 0 | |
| ii | Earnings per equity share | ||
| Basic earnings (loss) per share from continuing and discontinued operations | 10 | -4.5 | |
| Diluted earnings (loss) per share from continuing and discontinued operations | 9.99 | -4.5 | |
| 24 | Debt equity ratio | ||
| 25 | Debt service coverage ratio | ||
| 26 | Interest service coverage ratio | ||
| 27 | Disclosure of notes on financial results | Textual Information(1) | |
| Textual Information(1) | As cell of point no. 19 are blocked. The details of the same for Quarter ended December 31, 2025 are mentioned below: Total profit/(Loss) attributable to owners of parent is 2,820.66 Total profit/(Loss) attributable to non-controlling interests is 0 As cell of point no. 20 are blocked. The details of the same for Quarter ended December 31, 2025 are mentioned below: Total comprehensive income for the period attribtable to owners of parent is 2,840.10 Total comprehensive income for the period attribtable non-controlling interests is 0 As cell of point no. 19 are blocked. The details of the same for Nine months ended December 31, 2025 are mentioned below: Total profit/(Loss) attributable to owners of parent is (1,268.97) Total profit/(Loss) attributable to non-controlling interests is 0 As cell of point no. 20 are blocked. The details of the same for Nine months ended December 31, 2025 are mentioned below: Total comprehensive income for the period attribtable to owners of parent is (1,401.07) Total comprehensive income for the period attribtable non-controlling interests is 0 |
|---|
| Debt equity ratio | |
|---|---|
| Debt service coverage ratio | |
| Interest service coverage ratio |
| Particulars | 3 months/ 6 month ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |||||
|---|---|---|---|---|---|---|---|
| Date of start of reporting period | 01-10-2025 | 01-04-2025 | |||||
| Date of end of reporting period | 31-12-2025 | 31-12-2025 | |||||
| Whether results are audited or unaudited | Unaudited | Unaudited | |||||
| Nature of report standalone or consolidated | Standalone | Standalone | |||||
| 1 | Segment Revenue (Income) | ||||||
| (net sale/income from each segment should be disclosed) | |||||||
| Total Segment Revenue | |||||||
| Less: Inter segment revenue | |||||||
| Revenue from operations | |||||||
| 2 | Segment Result | ||||||
| Profit (+) / Loss (-) before tax and interest from each segment | |||||||
| Total Profit before tax | |||||||
| i. Finance cost | |||||||
| ii. Other Unallocable Expenditure net off Unallocable income | |||||||
| Profit before tax | |||||||
| 3 | (Segment Asset - Segment Liabilities) | ||||||
| Segment Asset | |||||||
| Total Segment Asset | |||||||
| Un-allocable Assets | null | null | |||||
| Net Segment Asset | null | null | |||||
| 4 | Segment Liabilities | ||||||
| Segment Liabilities | |||||||
| Total Segment Liabilities | |||||||
| Un-allocable Liabilities | null | null | |||||
| Net Segment Liabilities | null | null | |||||
| Disclosure of notes on segments | |||||||
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-10-2025 | 01-04-2025 |
| B | Date of end of reporting period | 31-12-2025 | 31-12-2025 |
| C | Whether results are audited or unaudited | Unaudited | Unaudited |
| D | Nature of report standalone or consolidated | Standalone | Standalone |
| Other comprehensive income [Abstract] | |||
| 1 | Amount of items that will not be reclassified to profit and loss | ||
| 1 | Items that will not be reclassified to profit or loss | 298.80 | (1,493.40) |
| Total Amount of items that will not be reclassified to profit and loss | 298.80 | (1,493.40) | |
| 2 | Income tax relating to items that will not be reclassified to profit or loss | 104.40 | (172.40) |
| 3 | Amount of items that will be reclassified to profit and loss | ||
| 1 | Items that will be reclassified to profit or loss | 0.00 | 0.00 |
| Total Amount of items that will be reclassified to profit and loss | 0.00 | 0.00 | |
| 4 | Income tax relating to items that will be reclassified to profit or loss | 0.00 | 0.00 |
| 5 | Total Other comprehensive income | 194.40 | (1,321.00) |